4.8 Article

The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1

Journal

NATURE CELL BIOLOGY
Volume 8, Issue 2, Pages 170-U48

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncb1352

Keywords

-

Categories

Funding

  1. NCI NIH HHS [K01 CA098092-02, K01 CA098092-06, K01 CA098092-03, K01 CA098092-04, K01 CA098092, K01 CA098092-05, K01 CA098092-01A2] Funding Source: Medline

Ask authors/readers for more resources

The Vpr protein of HIV-1 functions as a vital accessory gene by regulating various cellular functions, including cell differentiation, apoptosis, nuclear factor of kappa B (NF-kappa B) suppression and cell-cycle arrest of the host cell. Several reports have indicated that Vpr complexes with the glucocorticoid receptor (GR), but it remains unclear whether the GR pathway is required for Vpr to function(1). Here, we report that Vpr uses the GR pathway as a recruitment vehicle for the NF-kappa B co-activating protein, poly(ADP-ribose) polymerase(1) (PARP-1). The GR interaction with Vpr is both necessary and sufficient to facilitate this interaction by potentiating the formation of a Vpr-GR-PARP-1 complex. The recruitment of PARP-1 by the Vpr-GR complex prevents its nuclear localization, which is necessary for Vpr to suppress NF-kappa B. The association of GR with PARP-1 is not observed with steroid (glucocorticoid) treatment, indicating that the GR association with PARP-1 is a gain of function that is solely attributed to HIV-1 Vpr. These data provide important insights into Vpr biology and its role in HIV pathogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available